Literature DB >> 25196240

In vitro evaluation of ureteral contractility: a comparative assessment of human, porcine and sheep ureteral response to vardenafil.

Iason Kyriazis1, Panagiotis Kallidonis, Ioannis Georgiopoulos, Abdulrahman Al-Aown, George Sakellaropoulos, Jens-Uwe Stolzenburg, Evangelos Liatsikos.   

Abstract

OBJECTIVES: Basic science studies of ureteral physiology and pathophysiology are commonly performed on animal ureters due to several limitations associated with human ureteral sampling. In this work we question whether animal ureters are good replicas of human ureteral behavior for pharmacological studies.
MATERIALS AND METHODS: Ureteral rings from human, porcine and ovine ureters underwent the same organ bath protocol. After stimulation with KCl, ureters were subjected to different doses of vardenafil. Basic contractility and ureteral response to vardenafil were analyzed.
RESULTS: A different pattern of basic contractility was evidenced between species. Vardenafil administration induced a dose-dependent reduction in KCl-induced amplitude increase in human ureters and a dose-dependent reduction in autonomic contractile rhythm of porcine and ovine ureters. Although animal ureters could predict the relaxant response of human samples to vardenafil, its effect would have been overestimated using only animal models.
CONCLUSIONS: Human ureteral investigations cannot entirely be replaced by existing animal models since results of the latter will vary significantly according to the tested pharmaceutical agent.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25196240     DOI: 10.1159/000358601

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  1 in total

1.  Role of phosphodiesterase inhibitors in stent-related symptoms: a systematic review and meta-analysis.

Authors:  Gopal Sharma; Aditya Prakash Sharma; Ravimohan S Mavuduru; Sudheer K Devana; Girdhar Singh Bora; Shrawan K Singh; Arup K Mandal
Journal:  World J Urol       Date:  2019-06-28       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.